The approximately 28% weight loss demonstrated by retatrutide in Phase 3 trials challenges the historical assumption that bariatric surgery represents the upper limit of achievable weight reduction [2]
Microdosing GLP-1 GIP B12 for longevity A separate and distinct use case has emerged for tirzepatide and GLP-1 class agents: microdosing for metabolic health, anti-inflammatory effects, and longevity, independent of weight loss goals
Fatigue isnt listed as the most common side effect of semaglutide, but its something some patients do report, especially in the early stages of treatment
Resources for Women Who Are Pregnant and/or Breastfeeding Get easy-to-read information on benefits or risk of medications, drugs, or other exposures during pregnancy and while breastfeeding
How the ODT works The oral disintegrating tablet bypasses the traditional oral route
The color was a quality-control hack as much as a clinical feature